Stock search

Ticker or company name

ABBV card

ABBV price forecast

AbbVie$294,55

P/E now is 50,7. Average over 5 years: 59,3 (range 26–80). The stock is 15% below its history.

Base · FY2030

$331,92+5,3% a year

The base case gives 5,3% a year, below your target of 10%.

Settings

%

No analyst consensus: assumptions come from the company's last 5 years. Change any in the table.

Assumptions by year

FY2026FY2027FY2028FY2029FY2030
Revenue growth, %
Net margin, %
Change in shares, %
Payout ratio, %
P/E low
P/E base
P/E high
Revenue$64,8 bn$68,7 bn$72,7 bn$77,1 bn$81,7 bn
Net income$8,34 bn$8,84 bn$9,37 bn$9,92 bn$10,5 bn
EPS$4,65$4,87$5,10$5,34$5,60

Changed values are highlighted. Bear and bull cases: growth ∓ 10,6%, margin ∓ 2 pp, low and high P/E.

Price at year end

  • Base
  • Bear – Bull
  • now $294,55

The dot is the base case, the line runs from bear to bull, the dashed line is today's price.

Result at the end of FY2030

Bear$73,59

Price change
−75,0%
A year
−24,5%
Fair value today
$62,50
Margin of safety
−78,8%

Base$331,92

Price change
+12,7%
A year
+5,3%
Fair value today
$245,88
Margin of safety
−16,5%

Bull$835,71

Price change
+183,7%
A year
+30,7%
Fair value today
$599,63
Margin of safety
+103,6%

What growth the price implies

For the stock to return 10% a year, revenue must grow 11,9% a year to FY2030 at a 12,9% margin and P/E 59,3.

Growth over 5 years
6%
Analyst consensus
no data
In your model
6%

Calculated from your assumptions. Not an investment recommendation.

Base · FY2030$331,92+5,3% a year